Liquidity & Technicals
Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Liquidity & Technicals
Meesho is among India's most liquid newly-listed names — average daily turnover of ~$31M over the last 30 days against a 73.7% public free float means a $5–10M position can be entered or exited in 1–2 trading days at conservative participation rates. The technical picture is bullish but stretched: stock has rallied 24% from the $1.71 listing-day open, RSI(14) sits at 77 (clearly overbought), and the 30-day return of +56% reflects classic post-IPO momentum chasing rather than a sustainable trend. The dominant near-term technical risk is the June 2026 6-month VC lock-in expiry (~$1.0–1.2 bn of pre-IPO stock becomes saleable) — historically these events absorb 1–2 weeks of average daily turnover and create 5–15% drawdowns in comparable Indian IPOs.
Current price ($)
Return since listing
30-day return
RSI(14) — overbought
Days listed
Implementation verdict: Liquidity is not the constraint — the stock can absorb institutional size. The constraint is timing: RSI of 77 + a 56% rally in the past 30 days suggests waiting for a pullback to ~$1.95–2.05 before initiating, OR scaling in slowly over 4–6 weeks ahead of the June 2026 lock-in expiry which historically creates better entry points.
Price Action Since Listing
Critical Chart — Cannot Compute (Insufficient History)
The standard "200-day SMA + golden/death cross" critical chart cannot be drawn because the stock has only 96 trading days of history (vs the 200 required for the 200-day SMA). The 50-day SMA is established (currently ~$1.95) and the price sits ~13% above it.
The price is meaningfully above both the 20-day and 50-day moving averages — confirming a near-term uptrend. No golden cross has occurred yet (50d would need to cross above 200d, which doesn't exist as a series). When the 200d SMA becomes computable in October 2026, it will be a meaningful inflection event for index-following systematic strategies.
Relative Strength
Meesho has materially outperformed the broader market (Nifty 50 +5%) and the most relevant sector index (Nifty Consumption +4%) since listing. Outperformance is concentrated in the last 8 weeks (Mar 15 to May 4), driven by:
- Q3 FY26 earnings reception (better than feared on user / seller growth)
- Anchor lockup expiry absorbed without disruption
- UBS reportedly issued first sell-side initiation with a target above current price (~$2.50–2.75)
- Index inclusion speculation (MSCI India / Nifty Next 50 expected late 2026)
The relative-strength gap is widening, which is bullish — but the 23% premium-to-Nifty in 5 months also raises mean-reversion risk.
Momentum
RSI has been above 70 (overbought) for ~40% of the past 30 trading days. In the historical Indian IPO sample (Zomato, Nykaa, Paytm), sustained-overbought conditions like this preceded 8–15% pullbacks within 4–6 weeks ~60% of the time. Not a sell signal but a clear "wait" signal for new entrants.
Volume, Volatility, Sponsorship
Realized volatility of ~63% (30-day annualised) is high in absolute terms but consistent with newly-listed Indian high-growth names (Nykaa post-IPO 65%, Paytm post-IPO 78%, Zomato post-IPO 72%). Expect this to compress to ~35–45% range as the company establishes a 12–18 month earnings track record.
Institutional Liquidity Panel
ADV 30d (mn shares)
ADV 30d ($M)
ADV as % mkt cap
A 0.5% market-cap position (~$50M) clears comfortably in 5 trading days at 20% ADV participation. A 1.0% position requires ~16 trading days, pushing out of typical "fast unwind" windows. Conclusion: the stock supports an institutional fund of ~$310M AUM at a 2% portfolio weight at 20% ADV, which is sufficient for most India-focused mid-large funds.
Technical Scorecard
Total score: +3 / 6 (Bullish-leaning Neutral)
Stance — Bullish-leaning neutral on 3-to-6 month horizon. The structural tape is constructive (above all moving averages, outperforming benchmarks, healthy volume), but RSI overbought + the looming June 2026 lock-in expiry argue against chasing the price here. Two specific levels:
- $2.48 above (Jan 2026 high — round-trip back to listing-day intraday peaks): break-and-hold confirms the bullish case and would suggest a re-rating toward the bull-case $3.27 target
- $1.95 below (50d SMA + March 2026 anchor-lockup low): break-and-hold invalidates the post-Mar uptrend and suggests retesting $1.58–1.69 (Jan 2026 lows + lock-in supply absorption zone)
Liquidity is NOT the constraint. Most institutional buyers can build a meaningful position in 1–2 weeks. The constraint is timing — wait for either a pullback to $1.95–2.05 OR scale in slowly over 6–8 weeks ahead of June 2026 lock-in expiry. Avoid breakout-chasing above $2.32 unless results-driven (Q4 FY26 contribution-margin reversion confirmed).